Prognosis of Distant Metastatic Sites in Anterior Skull Base Malignancies

Abstract

Objective This study aimed to provide information regarding the prognosis of patients presenting with metastatic anterior skull base malignancies based upon histology and site of distant metastasis (DM).

Patients and Methods The National Cancer Database was queried for patients with anterior skull base malignant neoplasms with DM.

Outcomes Prognosis was compared between site of DM and tumor histologies. A multivariable Cox proportional hazards model was used to identify prognostic factors for overall survival (OS).

Results A total of 481 patients were identified. Lung was the most common site of DM (24.9%), followed by bone (22.2%), liver (5.6%), and brain (2.5%). Lung was the most common site for squamous cell carcinoma (SCCa) (28.3%), melanoma (37.7%), and adenoid cystic carcinoma (ACC; 31.4%). The median survival for patients presenting with metastatic disease regardless of tumor histology was 9.0 months (95% confidence interval [CI]: 8.2–10.3), and patients with metastasis to the liver had the best median survival at 15.5 months (95% CI: 10.5–25.6). The median survivals for the most common histologies, SCCa, melanoma, and ACC were 8.2 months (95% CI: 5.5–10.2), 10.5 months (95% CI: 8.7–14.1), and 15.0 months (95% CI: 11.1–61.1), respectively. Multivariable analysis demonstrated worse overall survival (OS) for older patients, higher Charlson-Deyo comorbidity scores, and tumors with higher grade and T stage. Compared with metastasis to bone, lung metastasis had better OS on multivariable analysis (hazard ratio [HR]: 0.70, 95% CI: 0.51–97). Adenoid cystic carcinoma had improved OS compared with SCCa (HR: 0.62, 95% CI: 0.39–99).

Conclusion Tumor histology, metastatic sites, and several disease factors affected prognosis in anterior skull base malignancies with DM.

Keywords

anterior skull base tumor - sinonasal malignancy - distant metastasis - primary tumor histology - survival

Publikationsverlauf

Eingereicht: 02. Februar 2021

Angenommen: 06. Mai 2021

Artikel online veröffentlicht:
10. Juni 2021

• References

• 1 Lund VJ, Stammberger H, Nicolai P. et al; European Rhinologic Society Advisory Board on Endoscopic Techniques in the Management of Nose, Paranasal Sinus and Skull Base Tumours. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 2010; 22 (22) 1-143
• 2 Raghavan P, Phillips CD. Magnetic resonance imaging of sinonasal malignancies. Top Magn Reson Imaging 2007; 18 (04) 259-267
• 3 Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P, Locatelli D. Sinonasal malignancies of anterior skull base: histology-driven treatment strategies. Otolaryngol Clin North Am 2016; 49 (01) 183-200
• 4 Kim BJ, Kim DW, Kim SW. et al. Endoscopic versus traditional craniofacial resection for patients with sinonasal tumors involving the anterior skull base. Clin Exp Otorhinolaryngol 2008; 1 (03) 148-153
• 5 Ferrari M, Bossi P, Mattavelli D, Ardighieri L, Nicolai P. Management of sinonasal adenocarcinomas with anterior skull base extension. J Neurooncol 2020; 150 (03) 405-417
• 6 Suarez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004; 26 (02) 136-144
• 7 Winchester DP, Stewart AK, Phillips JL, Ward EE. The national cancer data base: past, present, and future. Ann Surg Oncol 2010; 17 (01) 4-7
• 8 Surgeons ACo.. National Cancer Database database online. https://www.facs.org/quality-programs/cancer/ncdb Accessed 2020
• 9 Jack A, Percy C, Sobin L, Shanmugarathan S, Whelan S. International classification of diseases for oncology: ICD-O. World Health Organization; 2000
• 10 Brand RA. Standards of reporting: the CONSORT, QUORUM, and STROBE guidelines. In: Accessed 2009 Springer; https://link.springer.com/article/10.1007/s11999-009-0786-x
• 11 Carey RM, Godovchik J, Workman AD. et al. Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma. Int Forum Allergy Rhinol 2017; 7 (12) 1186-1194
• 12 Carey RM, Parasher AK, Workman AD. et al. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: analysis from the national cancer database. Laryngoscope 2018; 128 (03) 560-567
• 13 Carey RM, Fathy R, Shah RR. et al. Association of type of treatment facility with overall survival after a diagnosis of head and neck cancer. JAMA Netw Open 2020; 3 (01) e1919697
• 14 Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 1997; 174 (05) 495-498
• 15 Rhee CS, Won TB, Lee CH. et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope 2006; 116 (06) 982-986
• 16 Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y. Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer 2001; 92 (06) 1495-1503
• 17 Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977; 40 (01) 145-151
• 18 Kim BS, Vongtama R, Juillard G. Sinonasal undifferentiated carcinoma: case series and literature review. Am J Otolaryngol 2004; 25 (03) 162-166
• 19 Lin EM, Sparano A, Spalding A. et al. Sinonasal undifferentiated carcinoma: a 13-year experience at a single institution. Skull Base 2010; 20 (02) 61-67
• 20 Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002; 112 (8 Pt 1): 1450-1455
• 21 Roth TN, Gengler C, Huber GF, Holzmann D. Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 2010; 32 (10) 1385-1392
• 22 Cheng Y-F, Lai C-C, Ho C-Y, Shu C-H, Lin C-Z. Toward a better understanding of sinonasal mucosal melanoma: clinical review of 23 cases. J Chin Med Assoc 2007; 70 (01) 24-29
• 23 Bartell HL, Bedikian AY, Papadopoulos NE. et al. Biochemotherapy in patients with advanced head and neck mucosal melanoma. Head Neck 2008; 30 (12) 1592-1598
• 24 Gavriel H, McArthur G, Sizeland A, Henderson M. Review: mucosal melanoma of the head and neck. Melanoma Res 2011; 21 (04) 257-266
• 25 Wu S-G, Zhang W-W, Sun J-Y, Li FY, Lin Q, He ZY. Patterns of distant metastasis between histological types in esophageal cancer. Front Oncol 2018; 8: 302
• 26 Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol 2008; 179 (02) 474-477
• 27 Gerratana L, Fanotto V, Bonotto M. et al. Pattern of metastasis and outcome in patients with breast cancer. Clin Exp Metastasis 2015; 32 (02) 125-133
• 28 Sihto H, Lundin J, Lundin M. et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res 2011; 13 (05) R87
• 29 Wu Q, Li J, Zhu S. et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget 2017; 8 (17) 27990-27996
• 30 Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007; 110 (07) 1451-1456
• 31 Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 2012; 34 (06) 877-885
• 32 Bhattacharyya N. Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Head Neck Surg 2002; 128 (09) 1079-1083
• 33 Trope M, Triantafillou V, Kohanski MA. et al. Adenoid cystic carcinoma of the sinonasal tract: a review of the national cancer database. Paper presented at: International forum of allergy & rhinology. Accessed 2019 at: https://onlinelibrary.wiley.com/doi/abs/10.1002/alr.22255
• 34 Khademi B, Moradi A, Hoseini S, Mohammadianpanah M. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 2009; 13 (04) 191-199
• 35 Jakobsen MH, Larsen SK, Kirkegaard J, Hansen HS. Cancer of the nasal cavity and paranasal sinuses. Prognosis and outcome of treatment. Acta Oncol 1997; 36 (01) 27-31
• 36 Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92 (12) 3012-3029
• 37 McKay SP, Shibuya TY, Armstrong WB. et al. Cell carcinoma of the paranasal sinuses and skull base. Am J Otolaryngol 2007; 28 (05) 294-301
• 38 Desai PB, Bukatko AR, Simpson MC. et al. Comorbidity burden and nonclinical factors associated with sinonasal cancer all-cause mortality. Laryngoscope 2020; 130 (06) 1443-1449
• 39 Kuo P, Manes RP, Schwam ZG, Judson BL. Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg 2017; 156 (01) 132-136
• 40 Bhattacharyya N. Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 2003; 61 (09) 1016-1021
• 41 Agarwal P, Jones EA, Devaiah AK. Education and insurance status: Impact on treatment and survival of sinonasal cancer patients. Laryngoscope 2020; 130 (03) 649-658
• 42 2020 Standards and Resources. American College of Surgeons. Accessed July 24, 2020 at: https://www.facs.org/quality-programs/cancer/coc/standards/2020
• 43 Mohanty S, Bilimoria KY. Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol 2014; 109 (07) 629-630